ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,610.72
0.12%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Accelrys, Inc. (MM) (ACCL)

  7. Accelrys, Inc. (MM) (ACCL) News

Accelrys, Inc. (MM) (ACCL)

Accelrys, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACCL
DateTimeSourceHeadlineSymbolCompany
13/02/201515:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACCLAccelrys, Inc. (MM)
09/05/201415:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ACCLAccelrys, Inc. (MM)
08/05/201411:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACCLAccelrys, Inc. (MM)
07/05/201420:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACCLAccelrys, Inc. (MM)
05/05/201411:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACCLAccelrys, Inc. (MM)
05/05/201411:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:56Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:56Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201421:30Edgar (US Regulatory)(25-NSE)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201414:46Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
28/04/201421:22Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ACCLAccelrys, Inc. (MM)
28/04/201412:28MarketwiredPierre Fabre Laboratories Selects QUMAS DocCompliance to Manage Quality Documents Across Entire OrganizationNASDAQ:ACCLAccelrys, Inc. (MM)
24/04/201422:18Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
24/04/201411:06Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ACCLAccelrys, Inc. (MM)
23/04/201416:39Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
17/04/201413:00PR Newswire (US)New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug DiscoveryNASDAQ:ACCLAccelrys, Inc. (MM)
10/04/201413:00PR Newswire (US)Accelrys® Speeds Life Science Decisions with Next-Generation Insight®NASDAQ:ACCLAccelrys, Inc. (MM)
09/04/201416:37Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
09/04/201409:10Dow Jones NewsDassault Systemes Extends Offer for AccelrysNASDAQ:ACCLAccelrys, Inc. (MM)
27/03/201421:40PR Newswire (US)Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014NASDAQ:ACCLAccelrys, Inc. (MM)
27/03/201421:21PR Newswire (US)Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014NASDAQ:ACCLAccelrys, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ACCL

Your Recent History

LSE
TXP
Touchstone Exploration
LSE
BUR
Burford Capital
LSE
IPEL
Impellam
LSE
RRR
Red Rock Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved